Featured Applications
portable
Dedicated to your work. Not your workstation.
virtual
It’s time to bring all of your data together
scalable
Easily scale from multi-user to multi-site
smart subscription
We’ve made it effortless to stay current
ai
An AI for precision health
clinical applications
Everything you need to do great work
Xeleris V Base Package Applications
Advanced Reconstruction Package Applications
Quantitation Package Applications
Cardiology Reconstruction Package Applications
Neurology Package Applications
Dosimetry Package Applications
third-party applications
Tap into even more great applications for nuclear medicine
smart subscription
MI systems that keep getting better
Let’s put Xeleris V to work for your enterprise
Images are for illustration purposes only. See Xeleris V minimum requirements for supported client devices.
Quantitative Perfusion SPECT, Quantitative Gated SPECT, Quantitative Blood Pool GSPECT and Automatic Report Generator are trademarks of Cedars Sinai.
Emory Toolbox, Emory SyncTools, Emory SmartReport and Emory PETtools are trademarks of Syntermed Medical Imaging.
ASNC ImageGuide is a trademark of the American Society of Nuclear Cardiology.
Xeleris, Edison and Discovery are trademarks of GE.
1As demonstrated in an evaluation consisting of 99 SPECT/CT cases and three physicians, where each case was segmented manually and using the AI-based algorithm and evaluated by one of the physicians. In 89 of the cases, the AI-based segmentation met the success criteria of (a) less than three manual edits, and (b) lobe volume and activity within a predefined threshold compared to manual segmentation.
2Compared to Q.Lung on Xeleris 4 DR. As demonstrated in bench test using five SPECT/CT cases. The bench test covered the workflow for pulmonary embolism diagnosis and lung function assessment. Results may vary.
3Applicable for SPECT from Discovery NM/CT 670 CZT and NM/CT 870 CZT.
4Applicable for Discovery NM/CT 530c and Discovery NM/CT 570c.
5Compared to using Xeleris 4 DR Q.Volumetrix MI. As demonstrated in an evaluation at two sites consisting of 15 SPECT/CT cases and two physicians, where each case was processed by one of the two physicians. Results may vary.
6Compared to using Xeleris 4 DR Q.Volumetrix MI with manual or external software dose calculation. As demonstrated in an evaluation at two sites consisting of 15 SPECT/CT cases and two physicians, where each case was processed by one of the two physicians. Results may vary.
7Compared to using Xeleris 4 DR Q.Volumetrix with manual or external software dose calculation. As demonstrated in bench test using five SPECT/CT cases. The bench test covered the workflow from data loading to dose calculation using user pre-defined formulas. Results may vary.
Quantitative Perfusion SPECT, Quantitative Gated SPECT, Quantitative Blood Pool GSPECT and Automatic Report Generator are trademarks of Cedars Sinai.
Emory Toolbox, Emory SyncTools, Emory SmartReport and Emory PETtools are trademarks of Syntermed Medical Imaging.
ASNC ImageGuide is a trademark of the American Society of Nuclear Cardiology.
Xeleris, Edison and Discovery are trademarks of GE.
1As demonstrated in an evaluation consisting of 99 SPECT/CT cases and three physicians, where each case was segmented manually and using the AI-based algorithm and evaluated by one of the physicians. In 89 of the cases, the AI-based segmentation met the success criteria of (a) less than three manual edits, and (b) lobe volume and activity within a predefined threshold compared to manual segmentation.
2Compared to Q.Lung on Xeleris 4 DR. As demonstrated in bench test using five SPECT/CT cases. The bench test covered the workflow for pulmonary embolism diagnosis and lung function assessment. Results may vary.
3Applicable for SPECT from Discovery NM/CT 670 CZT and NM/CT 870 CZT.
4Applicable for Discovery NM/CT 530c and Discovery NM/CT 570c.
5Compared to using Xeleris 4 DR Q.Volumetrix MI. As demonstrated in an evaluation at two sites consisting of 15 SPECT/CT cases and two physicians, where each case was processed by one of the two physicians. Results may vary.
6Compared to using Xeleris 4 DR Q.Volumetrix MI with manual or external software dose calculation. As demonstrated in an evaluation at two sites consisting of 15 SPECT/CT cases and two physicians, where each case was processed by one of the two physicians. Results may vary.
7Compared to using Xeleris 4 DR Q.Volumetrix with manual or external software dose calculation. As demonstrated in bench test using five SPECT/CT cases. The bench test covered the workflow from data loading to dose calculation using user pre-defined formulas. Results may vary.